Name : Trust Wallet Token (TWT)
TWT Price : $1.167 -3.78%
Consensus Mechanism : BEP-20 Token
Volume: 45,368,929
Market Cap: 486,269,216
Shariah Judgement
This feature only can be accessed by subscribed users.
Shariah Status :
Last Screening: Q3 2023
Legitimacy:
Project:
Token:
Reward:
Shariah
Legitimacy
People
Shariah Analysis
Project/Products | Use Case | Status |
---|---|---|
Use Case | Status |
---|---|
System | Status | Interpretation |
---|---|---|
Legitimacy Analysis
Details | Status | |
---|---|---|
Whitepaper | ||
Project |
People Analysis
Details | Status | |
---|---|---|
Team |
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Overview
Trust Wallet is a mobile cryptocurrency wallet that stands as a reliable and secure solution for managing a variety of popular native assets. With a strong emphasis on privacy and security, Trust Wallet enables users to easily acquire, exchange, and hold numerous cryptocurrencies. Beyond its user-friendly interface, the wallet supports the management of unique ERC721 and ERC1155 crypto NFTs and game assets. Trust Wallet distinguishes itself as a decentralized and user-controlled wallet, ensuring that individuals have full control over their funds and keys, offering seamless access to DApps with user consent, and upholding the principles of privacy by not storing personal information or user funds.
Whitepaper & Documents
Sharlife uses TradingView technology to present price information through charts. TradingView serves as a charting platform catering to a worldwide community of traders and investors. With robust support across browsers, desktops, and mobile applications, the platform offers exceptional access to real-time data such as Dow Futures and BTC USD Chart, as well as the latest news, financial reports, stock screener, and economic .
COMMENTS
0 Comments